Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?

Creative Commons License

Araz M., Soydal Ç., Gündüz P., Kırmızı B. A., Bakırarar B., Sak S., ...More

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, vol.31, no.1, pp.49-56, 2022 (ESCI) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 31 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.4274/mirt.galenos.2022.59140
  • Journal Name: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.49-56
  • Keywords: Breast cancer, PET/CT, fluorodeoxyglucose, hormone receptor, CANCER, ESTROGEN, FEATURES, VOLUME, SUV
  • Ankara University Affiliated: Yes

Abstract

Objectives: This study aimed to investigate the role of preoperative 'fluorine-fluorodeoxyglucose (F-18-FDG) positron emission tomography/ computed tomography (PET/CT) radiomics features and metabolic parameters of primary breast tumors in predicting hormone receptor (HR) positivity.